In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption

Published:2013-10 Issue:10 Volume:54 Page:2858-2865
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Wang Sheng-Ping,Daniels Erin,Chen Ying,Castro-Perez Jose,Zhou Haihong,Akinsanya Karen O.,Previs Stephen F.,Roddy Thomas P.,Johns Douglas G.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference33 articles.

1. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels;Davidson;J. Am. Coll. Cardiol.,2006

2. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin;McKenney;J. Am. Coll. Cardiol.,2006

3. Effects of torcetrapib in patients at high risk for coronary events;Barter;N. Engl. J. Med.,2007

4. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone;Forrest;Br. J. Pharmacol.,2008

5. Mechanistic studies of blood pressure in rats treated with a series of cholesteryl ester transfer protein inhibitors;DePasquale;Drug Dev. Res.,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis;Progress in Lipid Research;2019-01

2. Present therapeutic role of cholesteryl ester transfer protein inhibitors;Pharmacological Research;2018-02

3. Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys;Journal of Lipid Research;2017-07

4. Evacetrapib;Cardiology in Review;2017-03

5. Case Histories: Anacetrapib;Comprehensive Medicinal Chemistry III;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3